Riluzole Tablet, Film Coated
Product Images NDC 68462-381

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Riluzole (NDC 68462-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
Kaplan-Meier survival curves comparing survival probability over 21 months between riluzole 50 mg twice daily (N=77) and placebo (N=78) groups. The vertical axis represents survival probability from 0.1 to 1.0, and the horizontal axis represents time in months from 0 to 21. The curve for riluzole shows higher survival probability compared to placebo over the study period.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A Kaplan-Meier survival curve graph comparing survival probability over 21 months between patients taking riluzole 50 mg twice daily (N=236) and a placebo group (N=242). The x-axis represents time in months, and the y-axis represents survival probability. The riluzole group shows a higher survival probability compared to the placebo group throughout the study period.*
FDA Label Image
FDA Label Image

Label 50mg

Label 50mg
Riluzole Tablets USP 50 mg film-coated tablets packaging label from Glenmark Pharmaceuticals Inc., USA. The label indicates Rx only and contains 60 tablets. Storage instructions specify keeping the product at 20° to 25°C (68° to 77°F) with protection from light. Manufacturer information includes Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430, and the product is made in India.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of riluzole, showing its molecular arrangement including trifluoromethoxy, benzothiazole, and amino groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.